Literature DB >> 6277437

Selective increases in the density of cerebellar beta-1-adrenergic receptors.

B B Wolfe, K P Minneman, P B Molinoff.   

Abstract

Destruction of noradrenergic neurons by 6-hydroxydopamine or chronic blockade of beta-adrenergic receptors with propranolol increased the density of beta 1-adrenergic receptors two-fold in rat cerebellum but had no effect on the density of beta 2-adrenergic receptors. The results suggest that even through beta 1 receptors comprise only 5-10% of the total number of Beta-adrenergic receptors in the cerebellum they are the receptors specifically innervated by noradrenergic neurons and they may thus be the physiologically important receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277437     DOI: 10.1016/0006-8993(82)90890-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Systemic phenoxybenzamine but not beta-adrenergic antagonists block noradrenergic inhibition of cerebellar Purkinje and hippocampal pyramidal neurons.

Authors:  D A Staunton; T H Svensson; G E Chouvet; G R Siggins; F E Bloom
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain.

Authors:  T C Rainbow; B Parsons; B B Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

Review 3.  The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.

Authors:  J N Joyce
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Independent regulation of beta 1- and beta 2-adrenoceptors.

Authors:  M Beer; S Hacker; J Poat; S M Stahl
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

5.  Changes in neurotransmitter sensitivity in the mouse neocortical slice following propranolol and theophylline administration.

Authors:  J Mally; J H Connick; T W Stone
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.